|
at 05:05 |
|
|
Enigma Biomedical USA, Inc. (EB USA) today announced that it has selected two (2) four-repeat tau (4R Tau) protein PET imaging biomarkers to advance into Phase 1 (Ph1) studies. Previously, EB USA executed an Exclusive License and Option Agreement...
|
|
at 05:00 |
|
|
"AI works 120 million times faster than the human brain," according to Dr. Neilank Jha, neurosurgeon, spine specialist and researcher. But AI ? artificial intelligence ? still needs human oversight. "The ideal approach is human/AI decision-making."...
|
|
at 03:20 |
|
|
LUND, SE / ACCESS Newswire / March 21, 2025 / BioInvent International AB ("BioInvent") , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today...
|
|
at 03:00 |
|
|
Top Doctors® Group, a leading healthtech company, has announced the 11th Edition of the Top Doctors Awards, recognising the 50 best private healthcare specialists in the UK.
Thousands of medical professionals voted to identify the most...
|
|
at 02:05 |
|
|
Almirall, a global pharmaceutical company dedicated to medical dermatology hosts the 16th edition of Skin Academy, a premier conference for healthcare professionals in the field of dermatology. This year's event features a comprehensive program aimed...
|
|
20 mar 2025 |
|
|
Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4...
|
|
|
